To Örebro University

oru.seÖrebro universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Effectiveness trials: critical data to help understand how respiratory medicines really work?
GSK Nordic Cluster, GSK, Solna, Sweden.
Örebro universitet, Institutionen för medicinska vetenskaper. Department of Respiratory Medicine.ORCID-id: 0000-0003-1926-8464
Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Department of Medical Sciences: Respiratory, Allergy & Sleep Research, Uppsala University, Uppsala, Sweden.
2019 (engelsk)Inngår i: European Clinical Respiratory Journal, ISSN 2001-8525, Vol. 6, nr 1, artikkel-id 1565804Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

Most of the information about the benefits, safety aspects, and cost effectiveness of pharmacological treatment in the respiratory field has been obtained from traditional efficacy studies, such as randomised controlled trials (RCT). The highly controlled environment of an RCT does not always reflect everyday practice. The collection, analysis, and application of effectiveness data to generate Real World Evidence (RWE) through pragmatic trials or observational studies therefore has the potential to improve decision making by regulators, payers, and clinicians. Despite calls for more RWE, effectiveness data are not widely used in decision making in the respiratory field. Recent advances in data capture, curation, and storage combined with new analytical tools have now made it feasible for effectiveness data to become routine sources of evidence to supplement traditional efficacy data. In this paper, we will examine some of the current data gaps, diverse types of effectiveness data, look at proposed frameworks for the positioning of effectiveness data, as well as provide examples from therapeutic areas. We will give examples of both previous effectiveness studies and studies that are ongoing within the respiratory field. Effectiveness data hold the potential to address several evidentiary gaps related to the effectiveness, safety, and value of treatments in patients with respiratory diseases.

sted, utgiver, år, opplag, sider
Taylor & Francis Group, 2019. Vol. 6, nr 1, artikkel-id 1565804
Emneord [en]
Effectiveness, real-world evidence, pragmatic trials, evidence-base, efficacy RCT, levels of evidence, respiratory disease, asthma, COPD, co-morbidity
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-72437DOI: 10.1080/20018525.2019.1565804ISI: 000457088000001PubMedID: 30728925Scopus ID: 2-s2.0-85070876148OAI: oai:DiVA.org:oru-72437DiVA, id: diva2:1288722
Tilgjengelig fra: 2019-02-14 Laget: 2019-02-14 Sist oppdatert: 2024-01-02bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Sundh, Josefin

Søk i DiVA

Av forfatter/redaktør
Sundh, Josefin
Av organisasjonen
I samme tidsskrift
European Clinical Respiratory Journal

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 316 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf